Clinical Trial Update: Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on the effects of sitagliptin (Januvia) on glucose in adults with Type 1 diabetes. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED